Evidence map›Paper›PMID 36457045›Full record

ArticleTrials2022

Sleep to Reduce Incident Depression Effectively (STRIDE): study protocol for a randomized controlled trial comparing stepped-care cognitive-behavioral therapy for insomnia versus sleep education control to prevent major depression.

Christopher L Drake, David A Kalmbach, Philip Cheng, Brian K Ahmedani, Edward L Peterson, Christine L M Joseph, Thomas Roth, Kelley M Kidwell, Chaewon Sagong

Registry-linked trialOpen access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03322774 (Sleep To Reduce Incident Depression Effectively), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03322774 nacompletednot on this map

Sleep To Reduce Incident Depression Effectively

TypeinterventionalSponsorHenry Ford Health SystemRan2018 to 2024Enrolled1,237ConditionsInsomnia, Primary, Major Depressive Disorder, RuminationArmsdigital Cognitive Behavioral Therapy for Insomnia, face-to-face Cognitive Behavioral Therapy for Insomnia, Sleep Hygiene Education Control
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Christopher L DrakeThomas Roth Sleep Disorders & Research Center, Henry Ford Health, Detroit, MI, 48202, USA. cdrake1@hfhs.org.
David A KalmbachThomas Roth Sleep Disorders & Research Center, Henry Ford Health, Detroit, MI, 48202, USA.
Philip ChengThomas Roth Sleep Disorders & Research Center, Henry Ford Health, Detroit, MI, 48202, USA.
Brian K AhmedaniCenter for Health Policy & Health Services Research, Henry Ford Health, Detroit, MI, 48202, USA.
Edward L PetersonDepartment of Public Health Services, Henry Ford Health, Detroit, MI, 48202, USA.
Christine L M JosephDepartment of Public Health Services, Henry Ford Health, Detroit, MI, 48202, USA.
Thomas RothThomas Roth Sleep Disorders & Research Center, Henry Ford Health, Detroit, MI, 48202, USA.
Kelley M KidwellDepartment of Biostatistics, University of Michigan, Ann Arbor, MI, 48109, USA.
Chaewon SagongThomas Roth Sleep Disorders & Research Center, Henry Ford Health, Detroit, MI, 48202, USA.
Henry Ford Health System · USUniversity of Michigan–Ann Arbor · US

Funding

Sleep to Reduce Incident Depression Effectively (STRIDE)R01MH122636 · NIMH · HENRY FORD HEALTH SYSTEM · PI DRAKE, CHRISTOPHER L · 2020 to 2022
$1.8M
Sleep to Reduce Incident Depression Effectively (STRIDE)R56MH115150 · NIMH · HENRY FORD HEALTH SYSTEM · PI DRAKE, CHRISTOPHER L · 2018 to 2019
$833k
NIMH NIH HHS R01 MH122636NIMH NIH HHS R01MH122636NIMH NIH HHS R56MH115150
6 · The paper itself

Abstract

backgroundPrevention of major depressive disorder (MDD) is a public health priority. Strategies targeting individuals at elevated risk for MDD may guide effective preventive care. Insomnia is a reliable precursor to depression, preceding half of all incident and relapse cases. Thus, insomnia may serve as a useful entry point for preventing MDD. Cognitive-behavioral therapy for insomnia (CBT-I) is recommended as the first-line treatment for insomnia, but widespread implementation is limited by a shortage of trained specialists. Innovative stepped-care approaches rooted in primary care can increase access to CBT-I and reduce rates of MDD. METHODS/

designWe propose a large-scale stepped-care clinical trial in the primary care setting that utilizes a sequential, multiple assignment, randomized trial (SMART) design to determine the effectiveness of dCBT-I alone and in combination with clinician-led CBT-I for insomnia and the prevention of MDD incidence and relapse. Specifically, our care model uses digital CBT-I (dCBT-I) as a first-line intervention to increase care access and reduce the need for specialist resources. Our proposal also adds clinician-led CBT-I for patients who do not remit with first-line intervention and need a more personalized approach from specialty care. We will evaluate negative repetitive thinking as a potential treatment mechanism by which dCBT-I and CBT-I benefit insomnia and depression outcomes. DISCUSSION: This project will test a highly scalable model of sleep care in a large primary care system to determine the potential for wide dissemination and implementation to address the high volume of population need for safe and effective insomnia treatment and associated prevention of depression.

trial registrationClinicalTrials.gov NCT03322774. Registered on October 26, 2017.

Indexed as

Cognitive Behavioral TherapyMajor Depressive DisorderSleep Initiation and Maintenance DisordersDepressionHumansPublic HealthRandomized Controlled Trials as TopicRecurrenceSleepCBT-IDepressionInsomniaPreventionRCTRumination

Identifiers

PMID36457045
PMCPMC9713737
OpenAlexW4310494358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.